• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US MBT CEM KEEL TIB TRAY SZ2; MBT TIBIAL TRAY : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US MBT CEM KEEL TIB TRAY SZ2; MBT TIBIAL TRAY : KNEE TIBIAL TRAY Back to Search Results
Catalog Number 129433120
Medical Device Problem Codes Loss of or Failure to Bond (1068); Migration (4003)
Health Effect - Clinical Codes Fall (1848); Pain (1994); Ambulation or Postural Difficulties (2544); Joint Laxity (4526); Swelling/ Edema (4577); Insufficient Information (4580)
Date of Event 07/08/2024
Type of Reportable Event Serious Injury
Event or Problem Description
Subject id: (b)(6).Study no: dots.Clinical adverse events received for migration/loosening.Device and procedure(relatedness).Device related: definitely.Procedure related: definitely not.Date of event: 8/jul/2024.Date of implant: information not provided.Date of revision: information not provided.Device location: right.Treatment/impact: information not provided.Geographical location: us.Additional event information: on (b)(6) 2024, medical records note the patient was noted to have had several falls.The patient is experiencing pain, a limp, and swelling.The patient has pseudolaxity, large varus collapse as well.Radiology reports show failure of tibial tray with subsidence.Physical examination shows a significant effusion, significant pseudolaxity, large varus collapse.Femoral component appears to be well fixed as well the patella is tracking centrally, with no tilt or subluxation.The patient has loose tibia with subsidence.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A records evaluation (mre) was not perform.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.H11 additional narrative: corrected: h6 (health effect - clinical and health impact code).
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MBT CEM KEEL TIB TRAY SZ2
Common Device Name
MBT TIBIAL TRAY : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
CORK MFG & MATERIAL WAREHOUSE
loughbeg ringaskiddy
cork
EI  
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key19827117
Report Number1818910-2024-15923
Device Sequence Number8666286
Product Code NJL
UDI-Device Identifier10603295025764
UDI-Public(01)10603295025764(17)220630(10)8588828
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2022
Device Catalogue Number129433120
Device Lot Number8585538
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/10/2024
Supplement Date Received by Manufacturer08/01/2024
08/01/2024
Initial Report FDA Received Date07/25/2024
Supplement Report FDA Received Date08/01/2024
08/07/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/27/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DEPUY CMW 2 20G.; PFC*SIGMA/OV/DOME PAT 3PEG,35.; SIG C/R POROCOAT FEM RT SZ 2.5.; SIG RP AOX CRV INS SZ2.5 15.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-